What is Blinding? From the Desk of Dr. Danielle Meadows Vice President of Research Programs & Operations This month, I want to continue drilling down on some of the considerations that go into study design—the first stage of the research
OMF’s Collaborative Center at Montreal, in collaboration with our Collaborative Center at Uppsala and the Computational Research Center for Complex Diseases, has released a new paper: Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic
OMF’s Collaborative Center at Montreal, in collaboration with our Melbourne ME/CFS Collaboration, has released a new paper: Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis. From the Desk of Dr. Alain Moreau, Director of
What is Proteomics? From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations Back in April, I elaborated a bit on what metabolomics is and how it’s used in ME/CFS research, as an important component of the
In August, OMF researchers from our collaborative centers at Stanford University and Montreal published a couple of papers investigating red blood cell movement and correlating a plasma marker to symptom profiles. I want to, of course, share these two publications
From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations Back in December of 2024, we announced a new large-scale biomarker project for ME/CFS, which we’re calling BioQuest. I am thrilled to be able to share an
As a mother, there is no greater calling than to care for your child—and when my daughter Amy fell ill with ME/CFS nearly eight years ago, I knew I would do whatever it took to support her. Watching her go
In 2016, Open Medicine Foundation (OMF) hosted the first of four in-person ME/CFS Research and Community Symposiums at Stanford University, each drawing strong attendance. During the COVID-19 pandemic, the Research Symposium transitioned to a virtual format, expanding access for researchers
Types of Biosamples From the Desk of Dr. Danielle Meadows,Vice President of Research Programs & Operations Last month I talked more in depth about ethics review as a critical part of the first stage of the research process when conducting
Each year on August 8, Severe ME/CFS Day, we pause to recognize the immense challenges faced by those living with the most debilitating form of ME/CFS. It’s a day to acknowledge the suffering, honor resilience, and remember the lives that
The 17th Invest in ME Research International ME Conference (IIMEC17) took place on May 30, 2025, in Cambridge, United Kingdom, marking the final event of International ME Conference Week 2025—a series of collaborative events featuring workshops, strategic meetings, and scientific
Today, we are pleased to share a new publication, Steroid Dynamics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Case-Control Study using Ultra Performance Supercritical Fluid Chromatography Tandem Mass Spectrometry. The Heart of the Matter OMF’s research centers in Uppsala and Melbourne
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then email or call OMF at 650-242-8669 to notify us of your donation or with any questions.
